Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience

Roxana M. Coman; Takuji Gotoda; Christopher E. Forsmark; Peter V. Draganov

doi:10.1055/s-0042-101788

Endoscopy International Open, Table of Contents

Endosc Int Open 2016; 04(06): E715-E721
DOI: 10.1055/s-0042-101788

Original article

Prospective evaluation of the clinical utility of endoscopic submucosal dissection (ESD) in patients with Barrett’s esophagus: a Western center experience

Roxana M. Coman

¹Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, Florida, United States

,

Takuji Gotoda

²Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan

,

Christopher E. Forsmark

¹Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, Florida, United States

,

Peter V. Draganov

¹Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, Florida, United States

› Author Affiliations

Abstract

Background and study aims: Endoscopic submucosal dissection (ESD) carries significant advantages over endoscopic mucosal resection. As such, ESD is an established therapy for esophageal squamous cell carcinoma but there are only limited data on ESD as therapy for Barrett’s esophagus (BE). Thus, we prospectively evaluated the outcomes of ESD in patients with BE with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC) performed in a Western center.

Patients and methods: This is a prospective cohort study. Indications for ESD included: (1) early EAC defined as lesions with intramucosal cancer or superficial submucosal invasion; (2) early EAC with positive lateral margin after EMR; and (3) nodularity with HGD that could not be removed en-bloc with EMR

Results: From October 2013 to July 2015, 36 consecutive patients (median age 69, 32 males) underwent ESD at our center. Median procedure time was 88 minutes, with median maximal diameter of resected specimens of 49 mm. En-bloc, R0, and curative resection rates were 100 %, 81 %, and 69 %, respectively.

Intramucosal EAC was found in 13 patients (36 %), and submucosal invasion in 13 patients (36 %). In 59 % of the cases, there was discrepancy in the pre- and post-ESD histopathologic diagnosis.

Adverse events occurred in 8 patients (22 %), including one episode of bleeding treated with endoscopy and seven esophageal strictures, which were successfully managed with dilations.

Conclusions: ESD for BE with HGD/early EAC is feasible and safe with resulting very high en-bloc and R0 resection rates. ESD provided for more accurate pathologic evaluation and significant discrepancy between the pre- and post-ESD histopathological diagnosis was noted.

Full Text

References

References
1 Edgren G, Adami HO, Weiderpass E et al. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 2013; 62: 1406-1414
2 Hazelton WD, Curtius K, Inadomi JM et al. The role of gastroesophageal reflux and other factors during progression to esophageal adenocarcinoma. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015;
3 Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. Journal of the National Cancer Institute 2005; 97: 142-146
4 de Jonge PJ, van Blankenstein M, Looman CW et al. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut 2010; 59: 1030-1036
5 Desai TK, Krishnan K, Samala N et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis. Gut 2012; 61: 970-976
6 Murray L, Watson P, Johnston B et al. Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ 2003; 327: 534-535
7 Wang KK. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. The American journal of gastroenterology 2008; 103: 788-797
8 Wani S, Sayana H, Sharma P. Endoscopic eradication of Barrett's esophagus. Gastrointest Endosc 2010; 71: 147-166
9 Zemler B, May A, Ell C et al. Early Barrett's carcinoma: the depth of infiltration of the tumour correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion. Virchows Archiv : an international journal of pathology 2010; 456: 609-614
10 Abrams JA, Fedi P, Vakiani E et al. Depth of resection using two different endoscopic mucosal resection techniques. Endoscopy 2008; 40: 395-399
11 Pech O, Behrens A, May A et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008; 57: 1200-1206
12 Park YM, Cho E, Kang HY et al. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc 2011; 25: 2666-2677
13 Gotoda T. Endoscopic resection for premalignant and malignant lesions of the gastrointestinal tract from the esophagus to the colon. Gastrointest Endosc Clin North Am 2008; 18: 435-450 , viii
14 Fujishiro M, Kodashima S, Goto O et al. Endoscopic submucosal dissection for esophageal squamous cell neoplasms. Dig Endosc 2009; 21: 109-115
15 Takahashi H, Arimura Y, Masao H et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 2010; 72: 255-264 e251 – e252
16 Neuhaus H, Terheggen G, Rutz EM et al. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus. Endoscopy 2012; 44: 1105-1113
17 Kagemoto K, Oka S, Tanaka S et al. Clinical outcomes of endoscopic submucosal dissection for superficial Barrett's adenocarcinoma. Gastrointest Endosc 2014; 80: 239-245
18 Hobel S, Dautel P, Baumbach R et al. Single center experience of endoscopic submucosal dissection (ESD) in early Barrett s adenocarcinoma. Surg Endosc 2015; 29: 1591-1597
19 Yoshinaga S, Gotoda T, Kusano C et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc 2008; 67: 202-209
20 Yamada M, Oda I, Nonaka S et al. Long-term outcome of endoscopic resection of superficial adenocarcinoma of the esophagogastric junction. Endoscopy 2013; 45: 992-996
21 Chevaux JB, Piessevaux H, Jouret-Mourin A et al. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett's neoplasia. Endoscopy 2015; 47: 103-112
22 Probst A, Aust D, Märkl B et al. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Endoscopy 2014; 47: 113-121
23 Sharma P, Dent J, Armstrong D. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C&M criteria. Gastroenterology 2006; 131: 1392-1399
24 Endoscopic Classification Review Group. Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005; 37: 570-578
25 Jeong JY, Oh YH, Yu YH et al. Does submucosal fibrosis affect the results of endoscopic submucosal dissection of early gastric tumors?. Gastrointest Endosc 2012; 76: 59-66
26 Ben-Menachem T, Decker GA. Committee ASoP et al. Adverse events of upper GI endoscopy. Gastrointest Endosc 2012; 76: 707-718
27 Omae M, Fujisaki J, Horiuchi Y et al. Safety, efficacy, and long-term outcomes for endoscopic submucosal dissection of early esophagogastric junction cancer. Gastric Cancer 2013; 16: 147-154
28 Hoteya S, Matsui A, Iizuka T et al. Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers. Digestion 2013; 87: 29-33
29 Farhat S, Chaussade S, Ponchon T et al. Endoscopic submucosal dissection in a European setting. A multi-institutional report of a technique in development. Endoscopy 2011; 43: 664-670
30 Draganov PV, Chang M, Coman RM et al. Role of observation of live cases done by Japanese experts in the acquisition of ESD skills by a western endoscopist. World J Gastroenterol 2014; 20: 4675-4680
31 Fujishiro M, Yahagi N, Kakushima N et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol 2006; 4: 688-694
32 Jung da H, Youn YH, Kim JH et al. Endoscopic submucosal dissection for colorectal lateral spreading tumors larger than 10 cm: is it feasible?. Gastrointest Endosc 2015; 81: 614-620
33 Kim YJ, Park JC, Kim JH et al. Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions. Endoscopy 2010; 42: 620-626
34 Won CS, Cho MY, Kim HS et al. Upgrade of lesions initially diagnosed as low-grade gastric dysplasia upon forceps biopsy following endoscopic resection. Gut Liver 2011; 5: 187-193
35 Takao M, Kakushima N, Takizawa K et al. Discrepancies in histologic diagnoses of early gastric cancer between biopsy and endoscopic mucosal resection specimens. Gastric Cance 2012; 15: 91-96
36 Sato H, Inoue H, Kobayashi Y et al. Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc 2013; 78: 250-257
37 Yamaguchi N, Isomoto H, Nakayama T et al. Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc 2011; 73: 1115-1121
38 Ono S, Fujishiro M, Niimi K et al. Predictors of postoperative stricture after esophageal endoscopic submucosal dissection for superficial squamous cell neoplasms. Endoscopy 2009; 41: 661-665
39 Coman RM, Gotoda T, Draganov PV. Training in endoscopic submucosal dissection. World J Gastrointest Endosc 2013; 5: 369-378